For the Inventor, By the Inventor

Enter inventor name

Ann Arbor, MI, United States of America

Donna McEachern

USPTO Granted Patents = 16 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 8.2

ph-index = 6

Forward Citations = 59(Granted Patents)

Company Filing History:

15 out of 3,381

University of Michigan

Jiangsu Ascentage Biomed Development Inc.

Years Active: 2013-2022

Loading Chart...

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11466028 - Fused 1,4-oxazepines as BET protein degraders (2022-10-11),

2. 11267822 - BET bromodomain protein degraders with cleavable linkers (2022-03-08),

3. 11046703 - Small molecule MDM2 protein degraders (2021-06-29),

4. 10781208 - 5,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitors (2020-09-22),

5. 10391175 - BET bromodomain inhibitors and therapeutic methods using the same (2019-08-27),

6. 10253044 - 9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors (2019-04-09),

7. 9783539 - Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors (2017-10-10),

8. 9745314 - MDM2 inhibitors and therapeutic methods using the same (2017-08-29),

9. 9675697 - BET bromodomain inhibitors and therapeutic methods using the same (2017-06-13),

10. 9580430 - 9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors (2017-02-28),

11. 9403856 - Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same (2016-08-02),

12. 9096625 - BCL-2/BCL-XL inhibitors and therapeutic methods using the same (2015-08-04),

13. 9079913 - Spiro-oxindole MDM2 antagonists (2015-07-14),

14. 8883771 - Bivalent inhibitors of IAP proteins and therapeutic methods using the same (2014-11-11),

15. 8877796 - Spiro-oxindole MDM2 antagonists (2014-11-04),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…